Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells

Cancer Research

Volumn 61, Issue 11, 2001, Pages 4583-4590

  Fedele, M ^a   Pierantoni, G M ^a   Berlingieri, M T ^a   Battista, S ^a   Baldassarre, G ^a   Munshi, N ^a   Dentice, M ^a   Thanos, D ^a   Santoro, M ^a   Viglietto, G ^a   Fusco, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; HIGH MOBILITY GROUP PROTEIN; TRANSCRIPTION FACTOR;

ACETYLATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL TRANSFORMATION; CHROMATIN; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; THYROID CELL;

EID: 0035360263     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Alternative processing of mRNA's coding for human HMG I and HMG Y proteins
2. cDNA cloning of the HMGI-c phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes
3. Mass spectrometric analysis of the HMGY protein from Lewis lung carcinoma. Identification of phosphorylation sites
4. The high mobility group protein HMG I (Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms
5. Reversal of intrinsic DNA bends in the IFN β gene enhancer by transcription factors and the architectural protein HMG I(Y)
6. HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures
7. The high mobility group protein HMG I(Y) is required for NF-kB-dependent vires induction of the human IFN-β gene
8. Virus induction of human IFN β gene expression requires the assembly of an enhanceosome
9. Retinoblastoma protein-dependent growth signal conflict and caspase activity are required for protein kinase C-signaled apoptosis of prostate epithelial cells
10. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C
11. High-mobility-group proteins P1, I, and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase
12. Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein
13. Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: Reduction of binding affinity
14. High level expression of the HMGI (Y) gene during embryonic development
15. Changes in nuclear proteins following transformation of rat thyroid epithelial cells by a murine sarcoma retrovirus
16. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes
17. Analysis of the HMGI nuclear proteins in meuse neoplastic cells induced by different procedures
18. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells
19. Determination of high mobility group I(Y) expression level in colorectal neoplasias: A potential diagnostic marker
20. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix
21. Human colorectal carcinomas express high levels of high mobility group HMGI (Y) proteins
22. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias
23. PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line
24. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis
25. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma
26. HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm
27. Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid
28. A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern
29. Acetylation of HMG I(Y) by CBP turns off IFN β expression by disrupting the enhanceosome
30. A new technique for the assay of the infectivity of human adenovirus 5 DNA
31. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasms
32. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining
33. 1 control in mammalian cells
34. 1 phase of the human cell cycle
35. D-type cyclin-dependent kinase activity in mammalian cells
36. 1 cyclin-dependent kinases
37. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 β-converting enzyme
38. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
39. CPP32/apopain is a key interleukin 1 β converting enzyme-like protease involved in Fas-mediated apoptosis
40. Yama/CPP32 β, a mammalian homologue of CED-3, is a poly(ADP-ribose) polymerase
41. Characterization of antipeptide antibodies directed towards the automodification domain and apoptotic fragment of poly (ADP-ribose) polymerase
42. Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor
43. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition
44. Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the β-interferon promoter
45. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma
46. Increased expression of high mobility group protein I (Y) in high grade prostate cancer determined by in situ hybridization
47. Apoptosis and the cell cycle